Higher Dispositional Optimism Predicts Better Health-Related Quality of Life After Esophageal Cancer Surgery: A Nationwide Population-Based Longitudinal Study

April 23, 2021 Leave a comment

This Swedish nationwide longitudinal research included 192 sufferers who underwent esophagectomy for most cancers. The publicity was dispositional optimism measured by the Life Orientation Check-Revised (LOT-R) at 1 yr post-surgery. Sufferers have been categorized into 4 subgroups (very low, reasonably low, reasonably excessive, and really excessive dispositional optimism) primarily based on the quartile of the LOT-R sum rating. The result was HRQL assessed by the European Group for Analysis and Therapy of Most cancers High quality of Life Questionnaire-Core 30 and High quality of Life Questionnaire-Esophago-Gastric module 25 at 1, 1.5, and a couple of years post-surgery.

Linear mixed-effects fashions, adjusted for potential confounders, have been used to look at the imply rating distinction (MSD) with 95% confidence interval of HRQL among the many 4 affected person subgroups. Sufferers with very excessive dispositional optimism reported clinically relevantly higher world high quality of life, emotional perform, and social perform (MSD vary 10-16) and fewer extreme signs in ache, dyspnea, diarrhea, consuming problem, anxiousness, dry mouth, bother with style, fear about weight reduction, and self-doubt about physique picture (MSD vary – 9 to – 22) than sufferers with decrease dispositional optimism.

Sufferers with reasonably excessive dispositional optimism reported clinically and statistically considerably higher world high quality of life (MSD 10) and fewer extreme diarrhea (MSD – 9) than sufferers with decrease dispositional optimism. Adjusted MSDs have been fixed over the three time factors in all features aside from consuming problem. Subsequently, the DF-based SA successfully solves the issue of fabric shedding and growing older, thus enhancing the soundness and injury threshold of the fiber laser.

COVID-19: unbalanced administration of occupational risks-case of the evaluation of the chemical threat associated to the usage of disinfectants within the dairy business in Morocco

Moroccan employers have a robust duty for the security and well being of their staff within the office and for shielding them from the chance of COVID-19 and any occupational hazards, as required by Moroccan legislation. As a consequence, industries, together with the agri-food sector, have put in place preventive measures to cope with this pandemic on a number of fronts, together with the usage of hydroalcoholic merchandise and bleach for private and floor disinfection.

These disinfection actions might remove or scale back the chance of coronavirus an infection, however the elevated use of those merchandise by staff may result in critical well being issues and improve the occupational chemical threat within the occasion of uncontrolled publicity. With the intention to analyze this threat within the dairy business in Morocco, we now have launched a qualitative and quantitative research to establish and assess the severity of chemical threat to which its staff are uncovered.

This includes an evaluation of the security information sheets [MSDS] of the disinfectants used and a well being and security survey of the customers of those merchandise, significantly for hand disinfection. This evaluation confirmed that this chemical threat is omnipresent and prevention measures are partially adopted. Certainly, the strengthening of well being security measures to fight COVID-19 has considerably elevated this threat, leading to a outstanding imbalance within the evaluation and administration of occupational dangers on this business.

That is the usage of the Danger Evaluation-Important Management Factors (HACCP)-Instrument for a First Danger Evaluation by Exercise Evaluation (OPERA) method, which we developed and proposed in a earlier research, for a simplified administration of chemical threat within the meals business, particularly in small- and medium-sized enterprises. These outcomes have led us to suggest corrective and preventive measures towards this threat to events and to undertake an built-in administration of meals and occupational well being dangers in a single system.

Higher Dispositional Optimism Predicts Better Health-Related Quality of Life After Esophageal Cancer Surgery: A Nationwide Population-Based Longitudinal Study

Monitoring-based deep studying methodology for temporomandibular joint segmentation

The form, measurement, and floor info regarding the glenoid fossae and condyles in temporomandibular joints (TMJ) are important for diagnosing and treating. Sufferers with TMJ illness usually have floor abrasion which can trigger fuzzy edges in computed tomography (CT) imaging, particularly for low-dose CT, making TMJ segmentation harder.  On this paper, an computerized segmentation algorithm primarily based on deep studying and post-processing was launched.
First, U-Internet was used to divide photos into three classes: glenoid fossae, condyles, and background. For structural fractures in these divided photos, the inner pressure constraint of a snake mannequin was used to replenish the integrity of the fracture boundary in a post-processing operation, and the preliminary boundary of the snake was obtained primarily based on the idea of the monitoring idea. A complete of 206 instances of low-dose CT have been used to confirm the effectiveness of the algorithm, and such indicators because the Cube coefficient (DC) and imply floor distance (MSD) have been used to judge the settlement between experimental outcomes and the gold normal.

CD28
MO28CFB(V100) 100 ug
EUR 60

CD28
MO28CFB(V25) 25 ug
EUR 60

CD28
MO28F(V100) 100 ug
EUR 60

CD28
MO28F(V25) 25 ug
EUR 60

CD28
MO28F(V500) 500 ug
EUR 60

CD28
MO28PE(V100) 100 ug
EUR 60

CD28
MO28PE(V25) 25 ug
EUR 60

CD28
MO28PP(V100) 100 ug
EUR 60

CD28
MO28PP(V25) 25 ug
EUR 60

CD28
MO28PP5.5(V100) 100 ug
EUR 60

CD28
MO28PP5.5(V25) 25 ug
EUR 60

CD28
MO28PU(V100) 100 ug
EUR 60

CD28
MO28PU(V500) 500 ug
EUR 60

CD28
PR27303 2 ug
EUR 229.2

E. coli gyrase ATPase assay Kit Plus (enzyme included)
T2A-100KE 100 assays
EUR 444.91
Description: This product includes the reaction buffer, DNA, E. coli gyrase, ATP and the phosphate detection reagent for 100 assays of DNA supercoiling reactions in a 384-well assay format.

P. aeruginosa Gyrase ATPase assay Kit Plus (enzyme included)
T2A-100KP 100 assays
EUR 444.91
Description: This product includes the reaction buffer, DNA, P. aeruginosa gyrase, ATP and the phosphate detection reagent for 100 assays of DNA supercoiling reactions in a 384-well assay format.

S. aureus gyrase ATPase assay Kit Plus (enzyme included)
T2A-100KS 100 assays
EUR 423.72
Description: This product includes the reaction buffer, DNA, S. aureus gyrase, ATP and the phosphate detection reagent for 100 assays of DNA supercoiling reactions in a 384-well assay format.

CD28 antigen (CD28) polyclonal antibody
ABP-PAB-10144 100 ug Ask for price

Cd28/ Rat Cd28 ELISA Kit
ELI-02294r 96 Tests
EUR 1063.2

pCDH-CuO-MCS-T2A-GFP co-inducible T2A lentivector
QM521A-1 10 ug
EUR 814.8

pCDH-CuO-MCS-T2A-RFP co-inducible T2A lentivector
QM522A-1 10 ug
EUR 814.8

CD28 Antibody
AF0014 200ul
EUR 420

CD28 siRNA
20-abx910984
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

CD28 siRNA
20-abx910985
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

CD28 Antibody
1-CSB-PA005199
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD28. Recognizes CD28 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

CD28 antibody
70R-49503 100 ul
EUR 344.4
Description: Purified Polyclonal CD28 antibody

CD28 antibody
70R-CR045 100 ug
EUR 360
Description: Affinity purified Rabbit polyclonal CD28 antibody

CD28 antibody
70R-9669 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal CD28 antibody

CD28 Antibody
46435-100ul 100ul
EUR 302.4

CD28 Peptide
42-404P 0.1 mg
EUR 405.6
Description: (IN) CD28 Peptide

Cd28 Peptide
42-448P 0.1 mg
EUR 405.6
Description: (IN) Cd28 Peptide

CD28 antibody
10R-6375 100 ug
EUR 230.4
Description: Syrian Hamster monoclonal CD28 antibody

CD28 antibody
10R-6376 100 ug
EUR 230.4
Description: Mouse monoclonal CD28 antibody

CD28 antibody
10R-CD28bHU 100 ul
EUR 560.4
Description: Mouse monoclonal CD28 antibody

CD28 antibody
10R-CD28dCKp 500 ug
EUR 483.6
Description: Mouse monoclonal CD28 antibody

CD28 antibody
10R-CD28dMS 500 ug
EUR 444
Description: Hamster monoclonal CD28 antibody

CD28 antibody
10R-CD28eMS 500 ug
EUR 444
Description: Hamster monoclonal CD28 antibody

CD28 siRNA
20-abx900903
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

CD28 Antibody
8683-002mg 0.02 mg
EUR 206.18
Description: N/A

CD28 Antibody
8683-01mg 0.1 mg
EUR 523.7
Description: N/A

CD28 Peptide
8683P 0.05 mg
EUR 197.7
Description: CD28 peptide

CD28/TP44
E21-D81 10ug
EUR 411.6

anti-CD28
YF-PA10780 50 ug
EUR 435.6
Description: Mouse polyclonal to CD28

Cd28 Antibody
R34402-100UG 100 ug
EUR 399

CD28 Antibody
R36029-100UG 100 ug
EUR 399

CD28 Antibody
V8232-100UG 100 ug
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V8232-20UG 20 ug
EUR 219
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V8232SAF-100UG 100 ug
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V8233-100UG 100 ug
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V8233-20UG 20 ug
EUR 219
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V8233SAF-100UG 100 ug
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2051-100UG 100 ug
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical Tcell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing Tcells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. it is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2051-20UG 20 ug
EUR 219
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical Tcell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing Tcells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. it is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2051CF488-100T 100 Tests
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2051PE-100T 100 Tests
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2051SAF-100UG 100 ug
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical Tcell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing Tcells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. it is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2053-100UG 100 ug
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2053-20UG 20 ug
EUR 219
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2053SAF-100UG 100 ug
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2054-100UG 100 ug
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2054-20UG 20 ug
EUR 219
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2054SAF-100UG 100 ug
EUR 499
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
F49999-0.08ML 0.08 ml
EUR 165

CD28 Antibody
F49999-0.4ML 0.4 ml
EUR 379

CD28 Antibody
V2987-100UG 100 ug
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2987-20UG 20 ug
EUR 219
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V2987SAF-100UG 100 ug
EUR 499
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V3258-100UG 100 ug
EUR 499
Description: CD28 is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V3258-20UG 20 ug
EUR 219
Description: CD28 is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

CD28 Antibody
V3258SAF-100UG 100 ug
EUR 499
Description: CD28 is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader.

pMy- BirA- T2A- eGFP
PVT10519 2 ug
EUR 361.2

pME-Cas9-T2A-GFP
PVT14646 2 ug
EUR 843.6

Recombinant Cynomolgus CD28 molecule/CD28(C-Fc)
CB24-10ug 10ug
EUR 120
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus CD28 molecule/CD28(C-Fc)
CB24-1mg 1mg
EUR 1338
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus CD28 molecule/CD28(C-Fc)
CB24-500ug 500ug
EUR 936
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus CD28 molecule/CD28(C-Fc)
CB24-50ug 50ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

T-cell-specific surface glycoprotein CD28/CD28
E21-I67 10ug
EUR 411.6

T2A-GFP Co-Expression HR Targeting Vector [T2A-GFP-pA-loxP-EF1?-RFP-T2A-Puro-pA-LoxP-MCS]
HR130PA-1 10 ug
EUR 1227.6

Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ)
78600 50 µl
EUR 1150
Description: The anti-CD19 CAR lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express the ScFv portion of anti-CD19 (clone FMC63) linked to 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge, 4-1BB, and CD3ζ signaling domains. 

pCDH-EF1-MCS*-T2A-GFP
CD526A-1 10 ug
EUR 783.6

pCDH-EF1-Luc-T2A-copGFP
PVT17649 2 ug
EUR 508.8

pCDH-EF1-Luc2-T2A-ZsGreen1
PVT17917 2 ug
EUR 508.8

pCDH- EF1- MCS- T2A- copGFP
PVT2336 2 ug
EUR 390

pcDNA3.1(+)-mDnmt1-T2A-EGFP Plasmid
PVTB50066-2a 2 ug
EUR 427.2

pUC18-CD274-T2A-EGFP Plasmid
PVT15948 2 ug
EUR 390

pTol2- Promoter- T2A- EGFP Plasmid
PVT1603 2 ug
EUR 390

CD28(204.12) Antibody
BNCA0164-250 250uL
EUR 459.6
Description: Primary antibody against CD28(204.12), APC conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCA0384-250 250uL
EUR 459.6
Description: Primary antibody against CD28(CB28), APC conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCAP0164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCAP0164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCAP0384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCAP0384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD28 Polyclonal Antibody
ABP52975-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of CD28 from Human. This CD28 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD28

CD28 Polyclonal Antibody
ABP52975-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of CD28 from Human. This CD28 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD28

CD28 Polyclonal Antibody
ABP52975-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of CD28 from Human. This CD28 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD28

CD28(204.12) Antibody
BNC610164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF660R conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC610164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF660R conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC610384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF660R conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC610384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF660R conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC680164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF568 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC680164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF568 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC680384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF568 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC680384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF568 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCR0164-250 250uL
EUR 459.6
Description: Primary antibody against CD28(204.12), RPE conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCR0384-250 250uL
EUR 459.6
Description: Primary antibody against CD28(CB28), RPE conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNUB0164-100 100uL
EUR 250.8
Description: Primary antibody against CD28(204.12), Concentration: 0.2mg/mL

CD28(204.12) Antibody
BNUB0164-500 500uL
EUR 549.6
Description: Primary antibody against CD28(204.12), Concentration: 0.2mg/mL

CD28(CB28) Antibody
BNUB0384-100 100uL
EUR 250.8
Description: Primary antibody against CD28(CB28), Concentration: 0.2mg/mL

CD28(CB28) Antibody
BNUB0384-500 500uL
EUR 549.6
Description: Primary antibody against CD28(CB28), Concentration: 0.2mg/mL

CD28(204.12) Antibody
BNC430164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF543 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC430164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF543 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC430384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF543 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC430384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF543 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC470164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF647 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC470164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF647 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC470384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF647 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC470384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF647 conjugate, Concentration: 0.1mg/mL

CD28 Blocking Peptide
AF0014-BP 1mg
EUR 234

CD28(204.12) Antibody
BNC400164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF640R conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC400164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF640R conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC400384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF640R conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC400384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF640R conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC880164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF488A conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC880164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF488A conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC880384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF488A conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC880384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF488A conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC810164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF680R conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC810164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF680R conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC810384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF680R conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC810384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF680R conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCP0164-250 250uL
EUR 459.6
Description: Primary antibody against CD28(204.12), PerCP conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCP0384-250 250uL
EUR 459.6
Description: Primary antibody against CD28(CB28), PerCP conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNUM0164-50 50uL
EUR 474
Description: Primary antibody against CD28(204.12), 1mg/mL

CD28(CB28) Antibody
BNUM0384-50 50uL
EUR 474
Description: Primary antibody against CD28(CB28), 1mg/mL

CD28(204.12) Antibody
BNC050164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF405M conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC050164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF405M conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC050384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF405M conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC050384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF405M conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC700164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF770 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC700164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF770 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC700384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF770 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC700384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF770 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC800164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF680 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC800164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF680 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC800384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF680 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC800384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF680 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCB0164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), Biotin conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCB0164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), Biotin conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCB0384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), Biotin conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCB0384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), Biotin conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC940164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF594 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC940164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF594 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC940384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF594 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC940384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF594 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC550164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), CF555 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNC550164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), CF555 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC550384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), CF555 conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNC550384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), CF555 conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCH0164-100 100uL
EUR 238.8
Description: Primary antibody against CD28(204.12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD28(204.12) Antibody
BNCH0164-500 500uL
EUR 652.8
Description: Primary antibody against CD28(204.12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCH0384-100 100uL
EUR 238.8
Description: Primary antibody against CD28(CB28), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD28(CB28) Antibody
BNCH0384-500 500uL
EUR 652.8
Description: Primary antibody against CD28(CB28), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
Utility of the SA in erbium-doped fiber laser and steady passive Q-switched operation with a most pulse power of 430.47 nJ is realized. By adjusting the polarization state and pump energy, high-power mode-locked pulses are generated with a pulse period and output energy of 199 fs and 54.13 mW, respectively. Additional, bound-state soliton pulses are obtained with a pulse width of 312 fs and soliton interval of 1.26 ps for the primary time primarily based on MXene supplies. Furthermore, by utility of the SA in ytterbium-doped fiber lasers, a steady dissipative soliton mode-locked pulse is obtained with a pulse width of 23 ps. These outcomes point out that the DF-based buried Mo2C as a novel SA offers a dependable methodology for all-fiber and multifunctional high-power ultrafast laser.

Leave a Reply

Your email address will not be published. Required fields are marked *